Dietary Selenite and Azadeoxycytidine Treatments Affect Dimethylhydrazine-Induced Aberrant Crypt Formation in Rat Colon and DNA Methylation in HT-29 Cells-Reference-Cited by-同舟云学术

Dietary Selenite and Azadeoxycytidine Treatments Affect Dimethylhydrazine-Induced Aberrant Crypt Formation in Rat Colon and DNA Methylation in HT-29 Cells

Published:2002-02-01 Issue:2 Volume:132 Page:292-297
ISSN:0022-3166
Container-title:The Journal of Nutrition
language:en
Short-container-title:

Author:

Davis Cindy D.¹,Uthus Eric O.¹

Affiliation:

1. U.S. Department of Agriculture, Grand Forks Human Nutrition Research Center, Grand Forks, ND 58202-9034

Publisher

Oxford University Press (OUP)

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://academic.oup.com/jn/article-pdf/132/2/292/24019725/4w0202000292.pdf

Reference42 articles.

1. Lessons from hereditary colorectal cancer;Kinzler;Cell,1996

2. Effect of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial;Clark;J. Am. Med. Assoc.,1996

3. Dietary selenium reduces the formation of aberrant crypts in rats administered 3,2′-dimethyl-4-aminobiphenyl;Feng;Toxicol. Appl. Pharmacol.,1999

4. Cancer-protective properties of high-selenium broccoli;Finley;J. Agric. Food Chem.,2001

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetics and Modification of Gene Expression in Metabolism;Precision Nutrition;2024

2. Current challenges and future implications of exploiting the omics data into nutrigenetics and nutrigenomics for personalized diagnosis and nutrition-based care;Nutrition;2023-06

3. Maternal Mineral Nutrition Regulates Fetal Genomic Programming in Cattle: A Review;Metabolites;2023-04-26

4. Higher blood selenium level is associated with lower risk of hyperhomocysteinemia in the elderly;Journal of Trace Elements in Medicine and Biology;2023-01

5. Dietary compounds as inhibitors of DNA methyltransferases;Role of Nutrigenomics in Modern-day Healthcare and Drug Discovery;2023